Emergent BioSolutions Inc (EBS)
2.175
-0.12
(-5.02%)
USD |
NYSE |
Apr 24, 16:00
2.17
0.00 (0.00%)
After-Hours: 17:00
Emergent BioSolutions Price: 2.175 for April 24, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 23, 2024 | 2.15 | 2.36 | 2.13 | 2.29 | 860965.0 |
Apr 22, 2024 | 2.04 | 2.29 | 1.995 | 2.16 | 1.393M |
Apr 19, 2024 | 1.84 | 2.06 | 1.84 | 2.04 | 936801.0 |
Apr 18, 2024 | 1.90 | 1.99 | 1.820 | 1.86 | 1.061M |
Apr 17, 2024 | 1.96 | 1.987 | 1.89 | 1.90 | 692033.0 |
Apr 16, 2024 | 1.96 | 2.04 | 1.91 | 1.95 | 859265.0 |
Apr 15, 2024 | 2.06 | 2.13 | 1.95 | 1.98 | 1.249M |
Apr 12, 2024 | 2.20 | 2.20 | 2.00 | 2.06 | 1.009M |
Apr 11, 2024 | 2.24 | 2.28 | 2.17 | 2.19 | 959852.0 |
Apr 10, 2024 | 2.27 | 2.28 | 2.20 | 2.23 | 888008.0 |
Apr 09, 2024 | 2.32 | 2.38 | 2.245 | 2.31 | 803018.0 |
Apr 08, 2024 | 2.32 | 2.34 | 2.25 | 2.32 | 841232.0 |
Apr 05, 2024 | 2.27 | 2.41 | 2.195 | 2.29 | 1.118M |
Apr 04, 2024 | 2.30 | 2.375 | 2.21 | 2.27 | 1.023M |
Apr 03, 2024 | 2.12 | 2.370 | 2.105 | 2.26 | 1.341M |
Apr 02, 2024 | 2.26 | 2.28 | 2.12 | 2.16 | 1.374M |
Apr 01, 2024 | 2.55 | 2.606 | 2.28 | 2.30 | 1.111M |
Mar 28, 2024 | 2.61 | 2.718 | 2.45 | 2.53 | 1.089M |
Mar 27, 2024 | 2.47 | 2.64 | 2.465 | 2.59 | 1.066M |
Mar 26, 2024 | 2.56 | 2.60 | 2.43 | 2.44 | 1.171M |
Mar 25, 2024 | 2.43 | 2.635 | 2.43 | 2.54 | 949444.0 |
Mar 22, 2024 | 2.47 | 2.51 | 2.40 | 2.41 | 1.221M |
Mar 21, 2024 | 2.56 | 2.59 | 2.47 | 2.47 | 810679.0 |
Mar 20, 2024 | 2.45 | 2.578 | 2.42 | 2.51 | 1.262M |
Mar 19, 2024 | 2.43 | 2.567 | 2.430 | 2.46 | 1.162M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.50
Minimum
Feb 07 2024
134.94
Maximum
Aug 13 2020
44.72
Average
44.34
Median
Price Benchmarks
Avid Bioservices Inc | 6.82 |
Viking Therapeutics Inc | 65.05 |
FibroGen Inc | 0.9804 |
Avinger Inc | 3.66 |
RAPT Therapeutics Inc | 7.92 |
Price Related Metrics
PS Ratio | 0.1088 |
PEG Ratio | -0.0007 |
Price to Book Value | 0.1749 |
Earnings Yield | -678.6% |
Market Cap | 113.54M |
PEGY Ratio | -0.0007 |